Despite the prominent expression and function of PDE4 enzymes in hearts, clinical usage of PDE4 inhibitors has yet to be fruitful because of an incomplete understanding of the complex expression and regulation of individual isoforms in cardiac diseases. This evidence concerns the gene PDE4A and heart disorder.